BMC Cancer is calling for submissions to our Collection on metabolism rewiring in cancer.
The first observations on metabolic alterations in cancer were made nearly a century ago by Otto Warburg, who discovered the metabolic differences between lactate production of cancer cells and non-malignant tissues. It is now well known that metabolic perturbations are a hallmark of cancer, which allows cancer cells to sustain their uncontrolled proliferation even in a frequently nutrient-poor environment. In the past decade, the field of cancer metabolism has become a topic of renewed interest, unrevealing the impact of metabolic rewiring in the cancer-microenvironment crosstalk and the onset of therapeutic resistance and metastasis.
In recognition of this important field, BMC Cancer has launched this Collection which encourages submissions including but not limited to those addressing:
• Genetic alterations involved in the metabolic reprogramming
• Metabolic alterations within the microenvironment
• Therapeutic approaches targeting cancer metabolism at the cellular or organismal levels
• Metabolites as tumor biomarkers
• Tumor metabolism as a diagnostic tool
• Tumor metabolism and therapy response imaging technologies
• Redox homeostasis in cancer metabolism
• Cancer metabolomics and multi-omics data integration
• Sex-specific metabolic alterations in cancers
• Improving in vitro cancer metabolism studies (new media formulations/conditions)
Image credit: © nobeastsofierce / Stock.adobe.com